von Willebrand factor, Jedi knight of the bloodstream

被引:348
作者
Springer, Timothy A. [1 ,2 ,3 ]
机构
[1] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Pharmacol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
PLATELET GLYCOPROTEIN IB; FACTOR A1 DOMAIN; WEIBEL-PALADE BODIES; FACTOR A2 DOMAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; HUMAN VONWILLEBRAND-FACTOR; IX-V COMPLEX; LEUCINE-RICH REPEATS; DEEP-VEIN THROMBOSIS; FACTOR A3 DOMAIN;
D O I
10.1182/blood-2014-05-378638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When blood vessels are cut, the forces in the bloodstream increase and change character. The dark side of these forces causes hemorrhage and death. However, von Willebrand factor (VWF), with help from our circulatory system and platelets, harnesses the same forces to form a hemostatic plug. Force and VWF function are so closely intertwined that, like members of the Jedi Order in the movie Star Wars who learn to use "the Force" to do good, VWF may be considered the Jedi knight of the bloodstream. The long length of VWF enables responsiveness to flow. The shape of VWF is predicted to alter from irregularly coiled to extended threadlike in the transition from shear to elongational flow at sites of hemostasis and thrombosis. Elongational force propagated through the length of VWF in its thread-like shape exposes its monomers for multi-meric binding to platelets and subendothelium and likely also increases affinity of the A1 domain for platelets. Specialized domains concatenate and compact VWF during biosynthesis. A2 domain unfolding by hydrodynamic force enables postsecretion regulation of VWF length. Mutations in VWF in von Willebrand disease contribute to and are illuminated by VWF biology. I attempt to integrate classic studies on the physiology of hemostatic plug formation into modern molecular understanding, and point out what remains to be learned.
引用
收藏
页码:1412 / 1425
页数:14
相关论文
共 112 条
[61]   O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions [J].
Nowak, Agata A. ;
Canis, Kevin ;
Riddell, Anne ;
Laffan, Michael A. ;
McKinnon, Thomas A. J. .
BLOOD, 2012, 120 (01) :214-222
[62]   Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type c module) from collagen IIA [J].
O'Leary, JM ;
Hamilton, JM ;
Deane, CM ;
Valeyev, NV ;
Sandell, LJ ;
Downing, AK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :53857-53866
[63]   Platelet-Type von Willebrand Disease: New Insights into the Molecular Pathophysiology of a Unique Platelet Defect [J].
Othman, Maha ;
Kaur, Harmanpreet ;
Emsley, Jonas .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (06) :663-673
[64]   Thrombosis in VonWillebrand disease [J].
Qureshi, Waqas ;
Hassan, Syed ;
Dabak, Vrushali ;
Kuriakose, Philip .
THROMBOSIS RESEARCH, 2012, 130 (05) :E255-E258
[65]   Two clusters of charged residues located in the electropositive face of the von Willebrand factor A1 domain are essential for heparin binding [J].
Rastegar-Lari, G ;
Villoutreix, BO ;
Ribba, AS ;
Legendre, P ;
Meyer, D ;
Baruch, D .
BIOCHEMISTRY, 2002, 41 (21) :6668-6678
[66]   Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor [J].
Riddell, Anne F. ;
Gomez, Keith ;
Millar, Carolyn M. ;
Mellars, Gillian ;
Gill, Saher ;
Brown, Simon A. ;
Sutherland, Megan ;
Laffan, Mike A. ;
McKinnon, Thomas A. J. .
BLOOD, 2009, 114 (16) :3489-3496
[67]   Adhesion mechanisms in platelet function [J].
Ruggeri, Zaverio M. ;
Mendolicchio, G. Loredana .
CIRCULATION RESEARCH, 2007, 100 (12) :1673-1685
[68]   Activation-independent platelet adhesion and aggregation under elevated shear stress [J].
Ruggeri, Zaverio M. ;
Orje, Jennifer N. ;
Habermann, Rolf ;
Federici, Augusto B. ;
Reininger, Armin J. .
BLOOD, 2006, 108 (06) :1903-1910
[69]   Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor [J].
Sadler, J. E. ;
Budde, U. ;
Eikenboom, J. C. J. ;
Favaloro, E. J. ;
Hill, F. G. H. ;
Holmberg, L. ;
Ingerslev, J. ;
Lee, C. A. ;
Lillicrap, D. ;
Mannucci, M. ;
Mazurier, C. ;
Meyer, D. ;
Nichols, W. L. ;
Nishino, M. ;
Peake, I. R. ;
Rodeghiero, F. ;
Schneppenheim, R. ;
Ruggeri, Z. M. ;
Srivastava, A. ;
Montgomery, R. R. ;
Federici, A. B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2103-2114
[70]   Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura [J].
Sadler, J. Evan .
BLOOD, 2008, 112 (01) :11-18